51
levocetirizin
Worth a lookShows low returns (0.0%), but strong incumbent ratings (4.7★) keeps it on the watch list.
Returns
Incredible0.0%return rate — above 5% kills the launch gate
Conversion
Incredible15.3%search→purchase rate — share of searches ending in a sale
Review moat
Great416.15avg incumbent reviews — the moat a new listing must climb
Avg price
Great€15.68avg listing price — sweet spot $15–$100
Price range
Good€6.98–€28.03cheapest to priciest tracked listing — scored on the share inside $15–$100
Growth
Good+29.8%90-day search growth — must beat 0% to launch
Competition
Okay70%top-5 click share — leaders hold, buyers still browse
Market size
Bad€94K€94K/yr · 39K searches
Brand share
Bad90%top-5 brand share — brand-locked demand
Quality gap
Bad4.7★avg incumbent rating — lower means beatable quality